Your browser doesn't support javascript.
loading
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.
Nakayama, Hideki; Tomizawa, Daisuke; Tanaka, Shiro; Iwamoto, Shotaro; Shimada, Akira; Saito, Akiko M; Yamashita, Yuka; Moritake, Hiroshi; Terui, Kiminori; Taga, Takashi; Matsuo, Hidemasa; Kosaka, Yoshiyuki; Koh, Katsuyoshi; Hosoi, Hajime; Kurosawa, Hidemitsu; Isoyama, Keiichi; Horibe, Keizo; Mizutani, Shuki; Adachi, Souichi.
Afiliación
  • Nakayama H; Department of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Tomizawa D; Department of Pediatrics, National Hospital Organization Fukuoka-Higashi Medical Center, Fukuoka, Japan.
  • Tanaka S; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Iwamoto S; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Shimada A; Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Saito AM; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Yamashita Y; Department of Pediatrics, Okayama University, Okayama, Japan.
  • Moritake H; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Terui K; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Taga T; Department of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Matsuo H; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Kosaka Y; Department of Pediatrics, Shiga University of Medical Science, Ohtsu, Japan.
  • Koh K; School of Human Health Science, Faculty of Medicine, Kyoto University, Kyoto, Japan.
  • Hosoi H; Department of Pediatric Hematology/Oncology, Hyougo Prefectural Kobe Children's Hospital, Kobe, Japan.
  • Kurosawa H; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Isoyama K; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Horibe K; Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan.
  • Mizutani S; Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Adachi S; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Pediatr Int ; 59(10): 1046-1052, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28771903
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vidarabina / Idarrubicina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Factor Estimulante de Colonias de Granulocitos / Citarabina / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Int Asunto de la revista: PEDIATRIA Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vidarabina / Idarrubicina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Factor Estimulante de Colonias de Granulocitos / Citarabina / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Int Asunto de la revista: PEDIATRIA Año: 2017 Tipo del documento: Article País de afiliación: Japón